Turner Syndrome Cytogenetics: A Complete Guide for Technologists
Published 2026-08-07
The 14-year-old who rewrote the rulebook
London, 1959. A 14-year-old girl is short for her age, has not started puberty, and has a webbed neck that her doctors have seen described in textbooks but never explained. Someone takes a bone marrow sample.
Charles E. Ford and his colleagues drop colchicine on the culture, freeze the cells mid-metaphase, and start counting. Three years earlier the field had finally settled on 46 as the human diploid number, so the counting part was new and the answer was supposed to be boring.
They count 45.
One X. No second sex chromosome anywhere. That single slide made Turner syndrome the first human sex chromosome abnormality ever identified, and it turned a vague clinical syndrome into something a technologist could see down a scope. Sixty-seven years later you are still counting those cells, just with better trypsin and a lot more rules.
Here is the part that still surprises people: 45,X is the only complete chromosomal monosomy compatible with postnatal human life. It shows up in roughly 1 in 2,500 to 3,000 live female births. It is also brutally lethal in utero, with an estimated 99% of 45,X conceptuses lost in the first trimester. The leading explanation for that surviving 1% is hidden somatic mosaicism: a normal cell line tucked away in some tissue that rescued the embryo. Keep that idea in your pocket, because it drives almost every counting rule later in this article.
Who described what, and when
The clinical picture arrived long before the chromosomes did.
| Year | Who | What they contributed |
|---|---|---|
| 1768 | Giovanni Battista Morgagni | Anatomical description of a patient with similar features |
| 1925 | N.A. Shereshevski | Clinical report of the phenotype |
| 1930 | Otto Ullrich | First systematic description of the full phenotype, in an 8-year-old girl |
| 1938 | Henry Turner | Cohort of seven women aged 15 to 23: short stature, sexual infantilism, gonadal dysgenesis, neck webbing, cubitus valgus |
| 1956 | Tjio and Levan (field consensus) | Human diploid number established as 46 |
| 1959 | Charles E. Ford | 45 chromosomes with a single X, from colchicine-arrested marrow |
The condition is still sometimes written as Ullrich-Turner syndrome, which is a fairer name than the one that stuck.
The Barr body detour
While the karyotype people were learning to count, the chromatin people were solving the same puzzle from the other end.
| Year | Discovery | Why it mattered |
|---|---|---|
| 1928 | Emil Heitz separates euchromatin from heterochromatin | Gave a vocabulary for "dense and silent" versus "open and transcribed" |
| 1949 | Barr and Bertram spot a dense body in female cat neurons, absent in males | The Barr body, originally called a nucleolar satellite |
| 1955 | Barr and K.L. Moore develop the buccal smear | First non-invasive clinical test for chromosomal sex, and the first practical Turner screen. No Barr body, suspect Turner |
The buccal smear is obsolete as a diagnostic, but the tissue choice was ahead of its time. You will see buccal cells come back at the end of this article for exactly the reason Barr picked them: they are easy to get and they are not blood.
Why two patients with the same diagnosis look nothing alike
Turner syndrome has famously variable expressivity. Three things drive it:
- The exact karyotype
- How much mosaicism there is, and in which tissues
- Whether the remaining X is structurally intact
That is not trivia. The indications written on the requisition decide how many cells you count and which probes you pull. So the clinical picture is a bench-workflow document, not just background reading.
The organ-by-organ summary
| System | Key findings | Frequency and notes |
|---|---|---|
| Growth | Short stature | Over 99%. Driven by SHOX haploinsufficiency |
| Skeletal | Cubitus valgus, Madelung deformity ("dinner fork sign"), short 4th metacarpal or metatarsal, high arched palate, microretrognathia, dental malocclusion, thin enamel, kyphosis and scoliosis risk | Facial bone variation also drives recurrent otitis media in childhood |
| Gonadal | Streak ovaries, delayed or absent puberty, primary amenorrhea, infertility | Over 90% of non-mosaic patients |
| Endocrine | Hypergonadotropic hypogonadism, elevated FSH and LH | Loss of ovarian estrogen negative feedback |
| Cardiovascular | Bicuspid aortic valve, coarctation of the aorta, hypertension, aortic root dilation and dissection risk | Left-sided obstructive lesions dominate. Major cause of mortality, needs lifelong echo |
| Lymphatic | Cystic hygroma prenatally, pterygium colli, low posterior hairline, neonatal hand and foot lymphedema | Hypoplastic lymphatics fail to drain |
| Renal | Horseshoe kidney and other malformations | Over 50%. An incidental horseshoe kidney is a legitimate reason to karyotype |
| Skin and nails | Multiple small pigmented nevi, hyperconvex or spoon-shaped nails, hair thinning with a widening part | Progressive over time |
| Neurocognitive | Verbal IQ preserved or above average, nonverbal learning disability: visuospatial, motor, and math deficits | No global intellectual disability in classic Turner |
The SHOX story in one paragraph
SHOX (Short Stature Homeobox) sits in pseudoautosomal region 1 (PAR1) on distal Xp and Yp. PAR1 escapes X-inactivation, so a euploid person expresses two working copies. Lose the second sex chromosome, or delete distal Xp structurally, and one copy has to do the job of two. Chondrocyte proliferation suffers, and the whole skeletal spectrum above follows from that single dosage problem.
Analytical red flag: severe intellectual disability, autism spectrum traits, or profound developmental delay in a patient with a Turner-like phenotype points hard at a small ring X that lost its X-inactivation center. That case is in the structural section below, and it is the single highest-yield concept in this article.
Worth saying plainly: with educational and psychological support, the large majority of adults with Turner syndrome are fully employed and living independent lives. Elevated rates of anxiety, obsessive behaviors, social isolation, and low self-confidence are real and documented, and they are not the whole story.
Dosage compensation, or why losing one X matters at all
Here is the question that trips up most students: if a normal female silences one X anyway, why does having only one X cause anything?
First, the normal machinery.
X-inactivation (lyonization) was proposed by Mary Lyon in 1961. In any somatic cell with more than one X, all but one are epigenetically silenced and condensed into the Barr body. Which X gets silenced is normally random, cell by cell, early in embryogenesis, and the choice is then inherited clonally by every daughter cell.
| Element | Location | Job |
|---|---|---|
| Xic (X-inactivation center) | Xq13.2 | Master control locus: 7 protein-coding sequences, 5 untranslated RNAs |
| XIST | Within Xic | Long non-coding RNA, never translated. Coats its own chromosome in cis, recruits methylation and histone deacetylation, locks in heterochromatin |
| Tsix | Antisense to XIST | Suppresses XIST. High Tsix marks the future active X, loss of Tsix lets XIST fire |
The answer: inactivation is not absolute
Roughly 15% to 20% of X genes escape lyonization. They cluster at the distal ends of both arms, especially in PAR1 and PAR2, with others scattered along the chromosome. In a 46,XX female those genes are transcribed from both the active and the inactive X. A 46,XY male matches that dose using homologous copies on the Y.
So a normal human needs two functional copies of every escape gene. A 45,X individual has one. That is haploinsufficiency, and every feature above, from SHOX short stature to lymphatic and gonadal dysgenesis, is a downstream consequence of that deficit.
The karyotypes you will actually see
| Karyotype group | Share of live-born Turner cases | Origin |
|---|---|---|
| Non-mosaic 45,X | 40% to 50% | Pre-zygotic meiotic non-disjunction |
| 45,X/46,XX mosaic | 15% to 20% | Post-zygotic mitotic error, usually anaphase lag |
| Structural X abnormalities | 20% to 30% | i(Xq), r(X), deletions, sSMC |
| 45,X/46,XY mosaic | Smaller subset, high stakes | Post-zygotic Y loss from a 46,XY zygote |
Classic monosomy X (45,X)
Non-disjunction is the failure of homologues to separate in meiosis I, or of sister chromatids in meiosis II. Either way you get a nullisomic gamete with no sex chromosome; fertilize it with a normal single-X gamete and you have a 45,X conceptus.
RFLP and microsatellite studies show the retained X is maternal in 60% to 75% of classic cases. Translation: the error usually happens in paternal spermatogenesis, whether by non-disjunction or anaphase lag with loss.
Two consequences that get tested:
- No advanced maternal age effect, unlike trisomy 21 or 18
- No established environmental risk factors
45,X/46,XX mosaicism
Mosaicism means two or more genetically distinct cell lines from one zygote. Start with a normal 46,XX fertilization, lose an X to anaphase lag during early cleavage, and a 45,X lineage grows up alongside the original cells.
The phenotype is generally milder: fewer left-sided heart defects, less metabolic syndrome and obesity, and a meaningfully higher chance of spontaneous menarche and natural pregnancy.
45,X/46,XY mosaicism, the one you go looking for
A 46,XY zygote loses the Y in a subset of cells. The patient presents as a phenotypic female with dysgenetic streak gonads, and there is hidden Y material in the mix.
| Finding | Clinical consequence |
|---|---|
| Any Y material with dysgenetic gonads, even low-level mosaic | 10% to 15% risk of gonadoblastoma |
| Gonadoblastoma | Benign mixed germ-stromal tumor, high rate of malignant transformation to dysgerminoma |
| Lab reports Y material | Management changes same day. Usually a strong recommendation for prophylactic bilateral gonadectomy |
This is why "rule out Y" is not an optional add-on for a Turner workup.
Structural X abnormalities and the failsafe
When the second X is structurally abnormal, biology stacks the deck: skewed, non-random X-inactivation preferentially silences the abnormal X and keeps the normal one active, minimizing imbalance.
Isochromosome Xq: 46,X,i(X)(q10)
The most common structural variant, 15% to 24% of all Turner karyotypes. An isochromosome is a mirror-image chromosome of two identical arms sharing a centromere, formed by transverse (not longitudinal) centromere misdivision or a U-type sister chromatid exchange in proximal Xp.
| Property | i(Xq) |
|---|---|
| Xp dosage | Monosomic |
| Xq dosage | Trisomic |
| Stature | Universally severe short stature, since SHOX lives on Xp |
| Signature association | Highest risk of Hashimoto thyroiditis of any Turner karyotype |
Ring X: 46,X,r(X) and the XIST question
Rings form when both telomeric ends break and the repair machinery fuses the sticky ends into a circle. Rings are mitotically unstable: sister chromatids tangle at anaphase, the ring breaks or is lost, and a secondary 45,X line often appears.
Everything about severity comes down to one thing: did the ring keep the Xic and a functional XIST?
| Ring type | What happened | Phenotype |
|---|---|---|
| XIST-positive | Breaks were distal, Xic spared, XIST silences the ring | Relatively typical, mild Turner phenotype from the genes deleted during ring formation |
| XIST-negative | Xq13.2 excised, ring physically cannot lyonize | Genes on the ring transcribe alongside the normal X: functional genomic disomy. Significant intellectual disability, structural brain anomalies, severe psychomotor retardation, autism spectrum disorder, Kabuki-like facial dysmorphism |
That second row is not classic Turner syndrome, and mistaking one for the other misroutes the whole clinical evaluation.
Small supernumerary marker chromosomes (sSMC)
Sometimes G-banding shows 46 chromosomes: a normal X plus a tiny unidentifiable extra. Origin decides everything.
| Marker origin | Risk |
|---|---|
| Y-derived | Gonadoblastoma |
| XIST-negative X fragment | Intellectual disability |
You cannot resolve this by banding. It takes FISH with centromeric probe cocktails or microarray to map the material.
On the bench: specimen to slide
G-banded metaphase karyotyping is still the gold standard here, because it shows numerical aneuploidy and macroscopic structure in one view. It only works if the pre-analytical side is clean.
| Requirement | Correct | Wrong, and why |
|---|---|---|
| Specimen | 1 to 5 mL peripheral whole blood | |
| Tube | Sodium heparin, green top. Anticoagulates without lysis or division inhibition | EDTA or citrate: reject. They chelate the calcium mitosis needs and cultures fail |
| Transport | Room temperature | Heat or refrigeration kills viability |
The processing sequence:
| Step | Action | Detail |
|---|---|---|
| 1 | Stimulation | Phytohemagglutinin (PHA) drives T-lymphocytes into mitosis |
| 2 | Culture | 72 hours in specialized media |
| 3 | Arrest | Colcemid or colchicine holds cells in metaphase |
| 4 | Hypotonic shock | Typically 0.075M KCl. Swells the membrane, disperses chromosomes |
| 5 | Fixation | 3:1 methanol to glacial acetic acid, repeated |
| 6 | Slide and band | Drop, dry, trypsin, Giemsa, and you have G-bands |
Prenatal specimens are amniocytes or chorionic villus sampling. The pre-analytical trap there is maternal cell contamination (MCC), where maternal decidual cells get cultured alongside fetal cells. Suspect MCC when a 46,XX line appears in an otherwise 46,XY culture, or whenever you are assessing a possible 45,X/46,XX mosaic. Document it, and consider QF-PCR or another molecular assay to confirm fetal origin.
The counting rules, which are the whole ballgame
Statistical power comes from cell count. Since G-banding is labor intensive, ACMG publishes minimums by indication.
Routine constitutional analysis
| Task | Minimum |
|---|---|
| Count for modal number | 20 cells |
| Full band-for-band analysis | 5 cells |
| Karyotype | 2 cells |
Detection sensitivity by cell count, 95% confidence
| Cells counted | Smallest mosaic clone reliably detected |
|---|---|
| 20 | 14% |
| 30 | 10% |
| 50 | 6% |
Turner syndrome is defined by mosaicism risk, so the routine 20 is not enough. Trigger an extended mosaicism workup when a sex chromosome abnormality is clinically suspected, or when even one 45,X cell turns up during a routine 20-cell count. Plan on 30 to 50 metaphases minimum.
Clonality: real mosaic or slide-making artifact?
Slide making is violent. Membranes rupture early, chromosomes drift off, and you get artificial monosomies. That is pseudomosaicism, and the clonality rule exists to filter it out.
| Abnormality type | Cells required to call a clone |
|---|---|
| Identical structural abnormality or extra chromosome | 2 cells |
| Identical missing chromosome | 3 cells |
Turner syndrome is loss, so you need three 45,X cells before you report 45,X mosaicism.
In prenatal amniocyte cultures, which grow as discrete adherent colonies, add the multiple colony rule: abnormal cells must appear across independent vessels or colonies. Several 45,X cells all sitting in one colony in one dish is an in vitro event, not the fetal genome.
When the blood karyotype is normal but the patient is not
Peripheral lymphocytes come from mesoderm, and the hematopoietic compartment is under heavy selective pressure. A 45,X line can be depleted or wiped out of blood over time while thriving in other germ layer derivatives.
So a convincing phenotype (severe short stature, streak ovaries, high FSH) with a clean 50-cell blood karyotype does not close the case.
| Next tissue | Germ layer | Why |
|---|---|---|
| Skin fibroblasts | Mesoderm, non-hematopoietic | Escapes blood-specific selection |
| Buccal mucosal swab | Ectoderm | Different germ layer entirely, uncultured, fast |
The payoff number: interphase FISH on uncultured buccal cells found that up to 29% of patients diagnosed with pure monosomy X by blood karyotype were actually tissue-specific mosaics with substantial 46,XX populations in buccal mucosa.
Molecular add-ons and what each one misses
G-banding sees down to roughly 5 to 10 Mb. Everything below that needs help.
| Method | Best at | Blind spots |
|---|---|---|
| G-banded karyotype | Whole-genome overview, aneuploidy, balanced rearrangements, mosaic clones by direct counting | Resolution limited to 5 to 10 Mb |
| FISH | Targeted questions fast. Interphase scoring of 100 to 500 nuclei catches ultra-low mosaicism, identifies sSMC origin, rules out Y | Only sees what you probe for |
| CMA | Genome-wide CNVs to roughly 50 kb, precise breakpoints, AOH on SNP platforms | Cannot detect balanced rearrangements. Needs 15% to 20% clone size for mosaicism |
| NIPT | Non-invasive prenatal screening from cffDNA | Screen, not a diagnosis. High false-positive rate for monosomy X |
FISH specifics
Workhorse probes: DXZ1 (X centromere alpha-satellite), DYZ3 (Y centromere), and SRY on distal Yp. Prefix ish for metaphase spreads, nuc ish for uncultured interphase nuclei.
Two high-yield uses:
- Metaphase FISH with a centromeric probe cocktail on an sSMC, to separate the gonadoblastoma risk from the intellectual disability risk
- Dual-color interphase X and Y FISH on buccal cells, scoring hundreds of ectodermal nuclei to rule out a hidden 46,XY line
CMA specifics
Pure 45,X reads as a continuous single-copy state across the whole X, with absence of heterozygosity (AOH) on SNP platforms. CMA is unbeatable for mapping exactly which genes an i(Xq) or r(X) gained or lost.
But know the limit cold: a 45,X/46,XX mosaic at 10% can be completely missed by microarray and caught easily by a technologist doing a 50-cell count or a 200-nucleus interphase FISH screen. That is your value on the bench, stated numerically.
Why NIPT false-positives cluster here
NIPT sequences cell-free fetal DNA from apoptotic placental trophoblast in maternal blood, maps millions of short reads, and flags read-depth deviations. For Turner it usually reports "high risk for X chromosome reduction." False positives are notably more common than for autosomal trisomies.
| Cause | Mechanism |
|---|---|
| Maternal mosaicism | Normal aging women lose an X in a fraction of lymphocytes. The assay detects it and blames the fetus |
| Vanishing twin | DNA from a demised co-twin still circulating |
| Confined placental mosaicism | Cytotrophoblast is 45,X while the inner cell mass forming the fetus is 46,XX |
Any positive NIPT for Turner syndrome requires confirmation by amniocentesis or CVS, then karyotype, interphase FISH, or CMA.
ISCN 2020 quick reference
ISCN is the standardized language that gets your findings from the microscope to the clinician intact. Total count, comma, sex chromosome complement, then structural abnormalities. Mosaic clones are separated by a forward slash, listed in decreasing frequency, with cells analyzed in square brackets.
Karyotypes
| Description | ISCN 2020 string |
|---|---|
| Classic monosomy X, non-mosaic, 20 cells | 45,X[20] |
| Mosaic Turner, 45,X clone predominating | mos 45,X[35]/46,XX[15] |
| Mosaic Turner with Y line, gonadoblastoma risk | mos 45,X[12]/46,XY[38] |
| Isochromosome Xq | 46,X,i(X)(q10)[20] |
| Mosaic isochromosome Xq | mos 45,X[10]/46,X,i(X)(q10)[40] |
| Ring X, breaks at p22.3 and q28 | 46,X,r(X)(p22.3q28)[20] |
| Mosaic ring X from mitotic instability | mos 45,X[18]/46,X,r(X)(p22.3q28)[32] |
FISH
| Application and findings | ISCN 2020 string |
|---|---|
| Interphase FISH, pure monosomy X, DXZ1, 1 signal in all 200 cells | nuc ish(DXZ1x1)[200] |
| Interphase FISH confirming mosaicism, 1 signal in 40 cells, 2 in 160 | nuc ish(DXZ1x1)[40]/nuc ish(DXZ1x2)[160] |
| Interphase Y screen, X and Y centromere probes, X only | nuc ish(DXZ1x1,DYZ3x0)[200] |
| Metaphase FISH, X centromere probe on an unidentified ring | ish r(X)(DXZ1+) |
Microarray
Prefix arr, genome build in brackets, chromosome and bands, nucleotide breakpoints, copy number state.
| Application and findings | ISCN 2020 string |
|---|---|
| Classic monosomy X, pter to qter loss | arr[GRCh38] Xp22.33q28(168,552_155,270,560)x1 |
| Isochromosome Xq, 1 copy Xp and 3 copies Xq | arr[GRCh38] Xp22.33p11.1(168,552_58,553,888)x1, Xq11.1q28(60,600,666_155,270,560)x3 |
| Mosaic monosomy X, tilde for intermediate copy state | arr[GRCh38] Xp22.33q28(168,552_155,270,560)x1~2 |
Five things to walk away with
| # | Takeaway | Why it matters at the scope |
|---|---|---|
| 1 | Count 30 to 50 cells, and remember the three-cell rule for loss | Mosaicism is the norm here, not the exception |
| 2 | A normal blood karyotype does not rule out Turner syndrome | Try fibroblasts or buccal cells. Up to 29% tissue-specific mosaics were missed in blood |
| 3 | Always screen for hidden Y material | 10% to 15% gonadoblastoma risk changes management immediately |
| 4 | For a ring X, ask about XIST first | XIST-negative means functional disomy and a completely different clinical picture |
| 5 | Be fluent in ISCN 2020 | Your findings are only as good as the string you report them in |
Ford counted to 45 on one slide and opened a field. The tools got better, the resolution improved, and NGS reads pile up faster than anyone can review them. The technologist is still the link between raw genomic data and an actual patient, and that has not changed since 1959.